Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2022-09-28 00:00:00 ET · period of report 2022-09-26 · accession 0001493152-22-027048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-28 | 2022-09-26 | ABEO | Amoroso Michael | Dir | A - Grant | $0.00 | +13.4K | 57.7K | +30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-26 | A | A | 13,400 | $0.00 | 57,711 | D | — | — | (F1) All of the restricted stock will vest on September 26, 2023. (F2) On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split. |